TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

550 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • Dementia / Alzheimer's

    VR&R: Providing Caregiver Respite by Managing BPSDs and Improving QoL in People with Dementia Using Immersive VR-Therapy

    Testing how immersive virtual reality at home affects dementia care

    📍 Acclaim Health · Oakville, Ontario · Get directions →

    The goal of this interventional trial is to learn about how immersive Virtual Reality (VR) therapy can be used at home by individuals with dementia, with assistance from their informal (e.g., friend/family) caregivers. The main question it aims to answer are: 1.

    ✓ Study care freeAges 65+Learn more →
  • Dementia / Alzheimer's

    Genetic Characterization of Movement Disorders and Dementias

    Studying genes in people with dementia and movement disorders

    📍 National Institute of Aging, Clinical Research Unit · Baltimore, MD · Get directions →

    Background: There are two basic types of movement disorders. Some cause excessive movement, some cause slowness or lack of movement.

    ✓ Study care freeAges 18–120Learn more →
  • Dementia / Alzheimer's

    LEADing Dementia End-of-Life Planning Conversations

    Testing conversations to plan end-of-life medical care for people with dementia

    📍 University of Utah College of Nursing · Salt Lake City, UT · Get directions →

    Advance care planning is important for all adults, but perhaps even more so for the 5.7 million persons with Alzheimer's disease or related dementia (ADRD), due to the progressive and protracted cognitive deterioration associated with the disease process. In the context of ADRD, medical decision-making at the end of life is typically left to one's care partner, who often does not have the knowledge or confidence in their ability to make such decisions.

    ✓ Study care freeAges 18+Learn more →
  • Dementia / Alzheimer's

    Remote Sensing for ADRD-Specific Activities Identification in Older Adults

    Testing smart-home sensors and AI to spot dementia-related daily activity changes

    📍 University of Missouri · Columbia, MO · Get directions →

    The investigators aim to use smart-home sensors and artificial intelligence (AI) to monitor and detect Alzheimer's Disease and Related Dementias (ADRD)-specific daily activities among older adults, with the goal of early symptom detection and personalized support. Dementia, which impacts memory and cognition, remains a global concern.

    ✓ Study care freeAges 50+Learn more →
  • DepressionDementia / Alzheimer's

    Investigating Dynamic Interactions in Distributed Cognitive Control Networks

    Testing brain activity during thinking tasks in people with depression or dementia

    📍 University of Alabama at Birmingham · Birmingham, AL · Get directions →

    The purpose of this study is to investigate the brain activity associated with cognitive tasks (thinking, reasoning, remembering) in order to understand how the brain works during certain tasks and to improve treatment for diseases like dementia and attention deficit disorders. Cognitive (thinking) impairment may include poor memory function, poor attention span, or psychiatric disorders (ex: ADD, depression).

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular diseaseCOPD (chronic lung disease)

    Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF

    Testing a remote mindful program to increase daily steps in people with COPD and heart failure

    📍 VA Boston · Boston, MA · +1 more US site · Get directions →

    The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard of care among 136 patients with COPD and/or HF. The main question it aims to answer is can this intervention promote physical activity as measured by daily step counts in sedentary patients with COPD and/or HF.

    ✓ Study care freeAges 40+Learn more →
  • Dementia / Alzheimer's

    Nabilone for Agitation in Frontotemporal Dementia

    Testing whether taking nabilone by mouth reduces agitation in dementia

    📍 University of British Columbia, St Paul's Hospital · Vancouver, British Columbia · Get directions →

    The primary goal of this study is to test the hypothesis that oral nabilone treatment will reduce agitation compared with placebo in patients with Frontotemporal Dementia (both behavioural variant frontotemporal dementia and primary progressive aphasia). The study population is defined as patients with probable Frontotemporal Dementia that meet the International Psychogeriatric Association criteria for agitation in cognitive disorders.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Dementia / Alzheimer'sParkinson's disease

    Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments

    Testing whether a tributyrin supplement helps memory, thinking, and balance in adults with Parkinson

    📍 Domino's Farms · Ann Arbor, MI · Get directions →

    The goal of this clinical trial is to learn if taking a tributyrin supplement works to improve memory and thinking and walking and balance in adults with Parkinson disease Parkinson disease dementia. It will also learn about the safety of tributyrin supplementation.

    ✓ Study care freePhase 1Ages 45+Learn more →
  • Dementia / Alzheimer's

    Phosphorylated Tau Levels in Donated Blood

    Testing how levels of a dementia-related blood protein relate to risk

    📍 University of Texas Health Science Center at Houston · Houston, TX · Get directions →

    Alzheimer's disease (AD) is characterized by the accumulation of tau pathology, and blood-based biomarkers such as phosphorylated tau-217 (pTau217) have been identified as sensitive and specific predictors of AD risk. Recent studies suggest that individuals with elevated pTau217 levels may be at increased risk for developing AD and cognitive dysfunction.

    ✓ Study care freeLearn more →
  • Heart / cardiovascular diseaseCOPD (chronic lung disease)

    Passive Heat Therapy for People With COPD

    Testing whether a 45-minute hot-water footbath improves blood flow in people with COPD

    📍 University of British Columbia · Kelowna, British Columbia · Get directions →

    People with Chronic Obstructive Pulmonary Disease (COPD) often develop high blood pressure and heart disease due to their sedentary lifestyle and difficulty exercising. The investigators will test if heating can mimic the health benefits of exercise by monitoring the increase in leg blood-flow using ultrasound during a 45-minute hot-water footbath.

    ✓ Study care freeAges 40+Learn more →
  • Dementia / Alzheimer's

    Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People at Risk for Alzheimer's Disease

    Testing light and sound stimulation to help prevent dementia in people at risk of Alzheimer’s

    📍 Massachusetts General Hospital · Boston, MA · +1 more US site · Get directions →

    Alzheimer's disease (AD) is characterized by significant memory loss, toxic protein deposits (amyloid and tau) in the brain, and changes in the gamma frequency band on EEG. Gamma waves are important for memory, and in patients with AD, there are fewer gamma waves in the brain.

    ✓ Study care freeAges 55–90Learn more →
  • Dementia / Alzheimer's

    Genetic Frontotemporal Dementia Initiative for Neurodevelopment

    Studying genetics in families affected by frontotemporal dementia

    📍 Western University · London, Ontario · Get directions →

    This is an international multi-centre cohort study of first and second degree family members of individuals who carry Frontotemporal Dementia (FTD) mutations in MAPT, GRN or C9ORF72 repeat expansions for youths between the ages 9-17.

    ✓ Study care freeAges 7–17Learn more →
  • Dementia / Alzheimer's

    A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses

    Testing 6 months of aerobic exercise to improve fitness in older adults with mild cognitive

    📍 Arizona State University · Phoenix, AZ · Get directions →

    The goal of this clinical trial is to test 6 months of aerobic exercise in older adults who are 65 years or older and have mild cognitive impairment (MCI) or probable/possible mild Alzheimer's Disease. The main questions it aims to answer are: * test the effects of aerobic exercise on aerobic fitness, white matter hyperintensity (WMH) volume, and patient-centered outcomes; * identify the best exercise to improve aerobic fitness and reduce non-responses over 6 months; and * examines the mechanisms of aerobic exercise's action on memory in older adults with early AD.

    ✓ Study care freeAges 65+Learn more →
  • Dementia / Alzheimer's

    Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry

    Collecting information on people with dementia receiving anti-amyloid antibody treatment

    📍 Georgia Memory Net Memory Assessment Clinic - Albany · Albany, GA · +7 more US sites · Get directions →

    The purpose of this registry is to compile information on patients who are receiving FDA-approved anti-amyloid mAbs in the course of their clinic visits in the Emory Cognitive Neurology Clinic and in Georgia Memory Net Memory Assessment Clinics.

    ✓ Study care freeAges 50–90Learn more →
  • Dementia / Alzheimer's

    A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease

    Testing the safety and how a drug works in people with Alzheimer’s

    📍 Clinical Trial Site · Montreal, · Get directions →

    The purpose of this study is to: * Evaluate the safety and tolerability of intrathecal (IT) ALN-5288 in patients with Alzheimer's Disease (AD) * Evaluate the pharmacodynamic (PD) and pharmacokinetic (PK) effects of ALN-5288 after dose administration

    ✓ Study care freePhase 1Ages 40–80Learn more →
  • Dementia / Alzheimer's

    Evaluating the Effectiveness of the Health App Recommendation Tool

    Testing a tool that suggests health apps for people with dementia

    📍 University of Pittsburgh · Pittsburgh, PA · Get directions →

    This study aims to assess the effectiveness of the Health App Recommendation Tool (HART), an evidence-based tool that evaluates app features and matches them to the needs, abilities, and preferences of individuals with Alzheimer's disease and related dementias (ADRD) or their caregivers. This novel tool is not an app in and of itself, but rather an assessment tool used to determine how well suited a given app is for a member of the ADRD or caregiver population.

    ✓ Study care freeAges 18–65Learn more →
  • Heart / cardiovascular diseaseDepression

    AI Platform for Fatigue and Depression Detection

    Testing how well an AI tool can spot fatigue and depression in heart patients

    📍 Indiana University · Indianapolis, IN · +1 more US site · Get directions →

    This observational study evaluates the accuracy of the Okaya AI platform in detecting fatigue and depression in cardiology patients, comparing its assessments to PHQ-9 and Fatigue Assessment Scale scores.

    ✓ Study care freeAges 18–99Learn more →
  • Dementia / Alzheimer's

    Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

    Testing a program to improve sleep for nursing home residents with dementia

    📍 Vivage/Beecan Corporation · Lakewood, CO · +2 more US sites · Get directions →

    This study seeks to improve clinical outcomes for an important, growing, and vulnerable population-nursing home residents with Alzheimer's disease or related dementias-by testing an evidence-based intervention to improve these residents' sleep. It will also examine the implementation and sustainment of this intervention.

    ✓ Study care freeAges 50+Learn more →
  • Dementia / Alzheimer's

    Tau Networks in Psychotic Alzheimer's Disease

    Studying brain processes behind psychotic symptoms in Alzheimer’s dementia

    📍 The Feinstein Institutes for Medical Research · Manhasset, NY · Get directions →

    This research project aims to understand the brain mechanisms behind the manifestation of psychotic symptoms in Alzheimer´s disease (AD), and nature of the unique relationship with tau pathology. Amongst the cognitive manifestations of psychosis are impairments related to frontal circuits (social cognition, working memory and executive function deficits).

    ✓ Study care freeAges 65–85Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    The Weight of Cardiovascular Disease

    Testing how a heart and metabolism clinic affects weight loss in obese adults with heart disease

    📍 Mayo Clinic in Rochester · Rochester, MN · Get directions →

    The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascular disease (CVD) at 12 months.

    ✓ Study care freeAges 18+Learn more →
  • Dementia / Alzheimer's

    Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium

    Studying sleep and daily rhythm markers in older adults after major surgery, in people with dementia

    📍 Massachusetts General Hospital · Boston, MA · Get directions →

    The goal of this prospective cohort study is to assess potential differences in sleep biomarkers in older adult patients undergoing major orthopedic surgery. The main questions it aims to answer are: 1.

    ✓ Study care freeAges 70+Learn more →
  • Dementia / Alzheimer's

    Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy

    Testing whether a blood test can find Alzheimer’s causes of dementia in hospital patients

    📍 Cumberland Medical Center · Crossville, TN · +5 more US sites · Get directions →

    The goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will result in an earlier diagnosis of underlying Alzheimer's disease. * Will this blood test have the ability to distinguish between Alzheimer's disease and other causes of cognitive impairment in the inpatient setting?

    ✓ Study care freeAges 60–90Learn more →
  • Dementia / Alzheimer's

    A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease

    Studying brain wave, muscle, and memory changes in dementia

    📍 Mayo Clinic Arizona · Scottsdale, AZ · Get directions →

    The purpose of this research study is to investigate how the brain, memory, thinking, and motor behavior change both in individuals with movement and/or cognitive disorders, as well as healthy individuals. Researchers will look at measurements of memory, thinking, brain wave and muscle activity, daily functioning, and brain scans to learn more about brain disorders such as Alzheimer disease and Lewy body disease.

    ✓ Study care freeAges 50–95Learn more →
  • Heart / cardiovascular diseaseKidney disease

    The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease

    Studying how kidney transplant affects tiny-heart-vessel blood flow in people with advanced chronic

    📍 Brigham and Women's Hospital · Boston, MA · Get directions →

    People with chronic kidney disease (CKD) often experience faster aging of the heart and blood vessels, which raises the risk of heart problems beyond traditional factors like high blood pressure or cholesterol. One early sign is reduced blood flow in the tiny vessels that supply the heart, measured by a positron emission tomography (PET) scan using a marker called myocardial flow reserve (MFR).

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    Adapting and Testing a Novel Digital Health Tool (PREVENT) to Improve Health Behavior Counseling and Cardiovascular Health in Rural Primary Care Clinics

    Testing a digital health tool to improve weight and heart care talks in rural clinics

    📍 Washington University in St. Louis · St Louis, MO · Get directions →

    The focus on this application is low-income, rural patients, since cardiovascular disease (CVD) prevalence is 40% higher among rural than urban residents. Health behavior counseling and follow-up care are required for patients with an elevated body mass index who have increased risk for CVD.

    ✓ Study care freeAges 18–64Learn more →
  • Dementia / Alzheimer's

    Swallowing Impairments in Adults With and Without Alzheimer's Disease

    Testing whether adults with Alzheimer’s disease have more swallowing problems than other older

    📍 Vanderbilt University Medical Center · Nashville, TN · Get directions →

    This research study is investigating whether people with Alzheimer's disease (AD) experience more changes to swallowing than their healthy age-matched peers. The prevalence of swallowing impairments in moderate-severe AD is high (85-93%), yet little is known about how swallow function evolves throughout the disease course in people with AD.

    ✓ Study care freeAges 60+Learn more →
  • Lupus (SLE)

    Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

    Testing whether adding two lupus medicines to standard care improves kidney results

    📍 AARA Clinical Research · Glendale, AZ · +6 more US sites · Get directions →

    This is a Phase IV, open-label, randomized trial to determine whether the combination of Belimumab (BEL) and Voclosporin (VCS), plus background therapy with Mycophenolate Mofetil (MMF), improves the proportion of patients with proliferative lupus nephritis achieving complete renal response (CRR) compared to proportion of patients achieving CRR from recent clinical trials. This protocol will additionally determine whether combination therapy using Belimumab (BEL) and Voclosporin (VCS) facilitates rapid discontinuation of MMF.

    ✓ Study care freePhase 4Ages 18–80Learn more →
  • Dementia / Alzheimer's

    Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease

    Testing a brain stimulation approach to study memory and thinking in people with early

    💵 May compensate

    📍 Massachusetts General Hospital · Charlestown, MA · Get directions →

    The project is a placebo-controlled study that aims to use closed-loop transcranial alternating current stimulation (tACS) to study patients with symptoms of mild cognitive impairment which is likely due to Alzheimer's disease or another form of dementia (AD-MCI). Patients will undergo an EEG and complete some questionnaires and computer tasks during each study visit.

    ✓ Study care freeAges 50–80Learn more →
  • Dementia / Alzheimer's

    Investigating Genetic Status in Patients Presenting to Clinic

    Studying genes to understand what causes dementia

    📍 Parkwood Institute · London, Ontario · Get directions →

    The causes of neurodegenerative dementias such as Frontotemporal Dementia, Lewy Body Disease and Alzheimer's disease are still largely unknown. While the contribution of some genetic mutations and polymorphisms is associated with autosomal dominant patterns of inheritance of these dementias, in many cases, the specific causative mutation in these families is not yet identified.

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightHeart / cardiovascular diseaseHigh blood pressure

    A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

    Testing a new digital tool doctors can use to prescribe exercise

    📍 UConn Health · Farmington, CT · +2 more US sites · Get directions →

    The investigators will conduct a feasibility and pilot efficacy randomized controlled trial to test the usability and user satisfaction of an evidence-based digital health tool the investigators developed for physicians to use to Prioritize Personalize Prescribe EXercise (P3-EX) to patients with cardiovascular disease (CVD) risk factors. The investigators will recruit 24 physicians from two local hospitals in CT, USA.

    ✓ Study care freeAges 18–64Learn more →
  • Dementia / Alzheimer's

    Cognitive Neurology Unit Clinical Registry

    Testing monoclonal antibody treatments for Alzheimer’s disease in people with dementia

    📍 Beth Israel Deaconess Medical Center · Boston, MA · Get directions →

    A Prospective Comparative Study Of Monoclonal Antibodies For The Treatment Of Alzheimer's Disease

    ✓ Study care freeAges 50–95Learn more →
  • Dementia / Alzheimer's

    dTMS for Subjective Cognitive Decline

    Testing deep brain magnetic stimulation in people with memory decline

    📍 Rotman Research Institute at Baycrest · Toronto, Ontario · Get directions →

    Deep transcranial magnetic stimulation (dTMS) is a brain stimulation technique that involves generating a brief magnetic field in a coil that is placed on the scalp. The magnetic field passes through the skull and induces a weak electrical current in the brain that briefly activates neural circuits at the stimulation site.

    ✓ Study care freeAges 55–70Learn more →
  • Dementia / Alzheimer's

    The Impact of Music Intervention on Sleep

    Testing whether a 1-month personalized music program improves sleep in people with dementia and

    📍 Duke University School of Nursing · Durham, NC · Get directions →

    The primary purpose of this Stage 1b NIH-funded clinical trial (K23AG073618, PI Petrovsky) is to determine the efficacy of a 1-month music intervention (Calming Music Personalized for Sleep Enhancement in PeRsons living with Dementia, CoMPoSER) on health outcomes in 72 dyads (144 participants) of persons living with dementia (PLWD) and their caregivers (Stage 1b). The secondary purpose of this research project is to examine the mechanism of stress reduction and sustained effects of the music intervention on PLWD and caregiver well-being.

    ✓ Study care freeAges 18–100Learn more →
  • Dementia / Alzheimer's

    Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

    Comparing a hospital care program with a family-involved version to help prevent delirium in older

    📍 Saddleback Medical Center · Orange, CA · +6 more US sites · Get directions →

    The goal of this clinical trial is to compare the Hospital Elder Life Program (HELP) with a family-augmented version of HELP (FAM-HELP), that includes family members and care partners, for the prevention of delirium in older patients during hospital admission. The main objectives of the trial are the following: 1.

    ✓ Study care freeAges 70+Learn more →
  • Dementia / Alzheimer's

    Triage Survey for Neurology Research Eligibility

    Survey to check who may qualify for neurology clinical trials for people with dementia

    📍 Copley Clinical · Boston, MA · +2 more US sites · Get directions →

    TRIAGE-Neuro is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored neurology clinical trials.

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular diseaseKidney disease

    A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

    Testing whether orforglipron changes heart outcomes in adults with heart disease and/or kidney

    📍 Instituto de Investigaciones Clínicas Bahia Blanca · Bahía Blanca, · Get directions →

    The purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation in the study will last about 5 years.

    ✓ Study care freePhase 3Ages 50+Learn more →
  • Dementia / Alzheimer's

    Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

    Testing an Alzheimer’s treatment in people with dementia and gum infection

    💵 May compensate

    📍 Banner Alzheimer's Institute · Phoenix, AZ · +38 more US sites · Get directions →

    This study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental decline in the last year and who have P. gingivalis (Pg) infection.

    ✓ Study care freePhase 2Ages 55–80Learn more →
  • Dementia / Alzheimer's

    TabCAT Brain Health Assessment in Primary Care

    Testing a tablet-based brain test to spot cognitive impairment in primary care

    📍 Kaiser Permanente Southern California Department of Research & Evaluation · Pasadena, CA · Get directions →

    Efficient and user-friendly paradigms to detect cognitive impairment, including dementia are needed in primary care. The TabCAT Brain Health Assessment accurately detects cognitive impairment via an appealing tablet interface with automated scoring and EMR integration.

    ✓ Study care freeAges 18+Learn more →
  • Dementia / Alzheimer's

    Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

    Using brain scans to find signs that healthy aging turns into Alzheimer’s dementia

    📍 Washington University School of Medicine · St Louis, MO · Get directions →

    To identify factors that signal the transition from asymptomatic (preclinical) to symptomatic Alzheimer disease (AD).

    ✓ Study care freeAges 18+Learn more →
  • Dementia / Alzheimer's

    Remotely-supervised Neuromodulation in PPA

    Testing home brain stimulation with speech therapy to improve speech in people with dementia

    📍 UCSF Memory and Aging Cener · San Francisco, CA · +1 more US site · Get directions →

    The goal of this clinical trial is to learn whether home-based brain stimulation combined with virtual speech-language therapy can improve communication abilities in adults with logopenic variant primary progressive aphasia (lvPPA), a language disorder most often caused by Alzheimer's disease. The main questions the study aims to answer are: * Is combining remotely supervised transcranial direct current stimulation (tDCS) with virtual speech-language therapy feasible and acceptable for people with lvPPA?

    ✓ Study care freeAges 40+Learn more →
  • Lupus (SLE)

    📍 Investigative Site · Beverly Hills, CA · +9 more US sites · Get directions →

    The goal of this clinical trial is to learn if VENT-03 works to treat patients with cutaneous lupus erythematosus (CLE) who may or may not have systemic lupus erythematosus (SLE). Another goal is to learn about the safety of VENT-03 and how it is processed by the body.

    ✓ Study care freePhase 2Ages 18–80Learn more →
  • Lupus (SLE)Eczema / atopic dermatitis

    Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

    Testing whether baricitinib is safe in people with Job syndrome and lupus or eczema

    📍 National Institutes of Health Clinical Center · Bethesda, MD · Get directions →

    Background: Autosomal dominant hyper-IgE syndrome (HIES), also called Job syndrome, is a genetic disorder that affects the immune system. It can cause skin and lung infections and problems with blood vessels, connective tissues, and bones.

    ✓ Study care freePhase 1Ages 12–120Learn more →
  • Dementia / Alzheimer's

    Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0

    Testing whether a care plan for suspected infections can reduce antibiotics in nursing home

    📍 Hebrew SeniorLife · Boston, MA · Get directions →

    The goal of this pragmatic cluster randomized clinical trial is to compare management of suspected infection in nursing home residents with dementia The main questions it aims to answer whether residents with dementia in nursing homes randomized to use a multicomponent intervention to optimize suspected infection management ( versus usual care) use less antibiotics and fewer burdensome interventions.

    ✓ Study care freeAges 60–106Learn more →
  • Dementia / Alzheimer's

    Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

    Testing the safety and effects of two drugs for agitation in Alzheimer’s dementia

    📍 Esperanza Clinical · Murrieta, CA · +8 more US sites · Get directions →

    The goal of this clinical trial is to evaluate the safety and efficacy of EXV-802 and EXV-801 in treatment of agitation in participants with Alzheimer's Disease dementia.

    ✓ Study care freePhase 2Ages 55–90Learn more →
  • Dementia / Alzheimer's

    Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation

    Testing whether noninvasive brain stimulation can improve memory in Alzheimer’s

    📍 677 Beacon St. Room 308 · Boston, MA · Get directions →

    The investigators will evaluate the theory that Alzheimer's disease-related memory impairment derives from the inefficient orchestration of rhythmic activity at the level of large-scale cortical networks. The results as expected to elucidate AD-related pathophysiology and set groundwork for the development of drug-free interventions for improving memory in AD and related dementias.

    ✓ Study care freeAges 50–100Learn more →
  • Dementia / Alzheimer'sParkinson's disease

    PET Imaging Evaluation of [11C]SY08

    Testing a PET scan tracer to detect alpha-synuclein protein clumps in dementia and Parkinson’s

    📍 MGH · Charlestown, MA · Get directions →

    The overall goal of the proposed research is to evaluate the use of \[11C\]SY08 as a PET radiotracer for aggregated alpha synuclein (αS) in individuals with Parkinson's disease (PD), Multiple system atrophy (MSA), Dementia with Lewy Bodies (DLB) and healthy controls. The purpose of this study is to evaluate the use of \[11C\]SY08 as a PET radiotracer for αS fibrils in individuals with PD, MSA, DLB and healthy controls.

    ✓ Study care freeEarly Phase 1Ages 50–80Learn more →
  • Dementia / Alzheimer's

    Rifaximin SSD in Dementia Trial

    Testing a new form of rifaximin to change gut microbes in people with dementia

    📍 Richmond VA Medical Center · Richmond, VA · Get directions →

    Using a new formulation of rifaximin, a non-absorbable antibiotic, to test if it can affect microbes in the gut of patients with dementia favorably.

    ✓ Study care freePhase 1Ages 65+Learn more →
  • Dementia / Alzheimer's

    Remote tDCS and Chair Yoga for Chronic Knee Pain in Alzheimer's Patients

    Testing home tDCS and chair yoga, led remotely, for knee pain in Alzheimer’s

    📍 University of Arizona College of Nursing · Tucson, AZ · Get directions →

    This study aims to evaluate the feasibility, acceptability, and preliminary effects of a home-based, remotely supervised intervention combining transcranial direct current stimulation (tDCS) and online chair yoga (OCY) to manage chronic knee pain in older adults with Alzheimer's Disease and Related Dementias (ADRD). Chronic knee pain is prevalent among individuals with ADRD and is often underdiagnosed and undertreated, contributing to neuropsychiatric symptoms, reduced quality of life, and increased caregiver burden.

    ✓ Study care freeAges 60+Learn more →
  • Dementia / Alzheimer's

    University of Central Florida Music Study

    Testing whether music therapy affects brain-related changes in people with dementia

    📍 University of Central Florida · Orlando, FL · Get directions →

    The purpose of this study is to scientifically validate the impact of music therapy on Alzheimer's disease (AD) by analyzing molecular biomarkers in salivary exosomes. Exosomes are extracellular vesicles that carry molecular signals from brain cells, providing a non-invasive method to assess physiological changes.

    ✓ Study care freeAges 50+Learn more →
  • Dementia / Alzheimer's

    Cannabidiol Medication Intervention Trial

    Testing CBD capsules to see if they help agitation in people with dementia

    📍 University of Calgary · Calgary, Alberta · Get directions →

    CALM-IT is a Randomized, double-blind, placebo-controlled cross-over clinical trial. Safety and efficacy of cannabidiol (CBD) capsules assessed for managing agitation in patients with AD and to identify novel biomarkers of agitation severity and treatment response.

    ✓ Study care freePhase 2Ages 55+Learn more →
  • Lupus (SLE)

    CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

    Testing a cell therapy made from a person’s own immune cells for lupus

    📍 Children's Hospital of Philadelphia · Philadelphia, PA · Get directions →

    This is a single-center, single-arm, open-label phase 1/2 study of CART19 in children and young adults with refractory Systemic lupus erythematosus (SLE), including both patients diagnosed with lupus nephritis (LN) and patients with non-renal Systemic lupus erythematosus (SLE). Phase 1 will evaluate the safety of CART19 in 6-12 patients with Systemic lupus erythematosus (SLE).

    ✓ Study care freePhase 1Ages 12–29Learn more →
  • Heart / cardiovascular diseaseDepressionAnxiety

    Improving Care and Mental Well-Being for Adults With Heart Failure

    Testing ways to improve mental well-being for adults with heart failure

    📍 Seaway Valley Community Health Centre (Cardiac Rehab Program) · Cornwall, Ontario · Get directions →

    Heart failure is a high-risk, chronic condition that impacts patients' mental health. Approximately 50% of heart failure patients experience comorbid mental health conditions, such as stress, depression and anxiety, which affect their day-to-day lives.

    ✓ Study care freeAges 40+Learn more →
  • Lupus (SLE)

    US Zamto-cel Autoimmune Diseases

    Testing the safety of an experimental cell therapy for lupus

    📍 Froedtert Hospital and the Medical College of Wisconsin · Milwaukee, WI · Get directions →

    AID is a phase I multi-cohort study to assess the safety and tolerability of zamtocabtagene autoleucel (zamto-cel) in patients with refractory autoimmune diseases (SLE-Non renal, SLE-LN, SSc/dcSSc) after receiving standard therapy.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Dementia / Alzheimer's

    Activity Tracking, Care Partner Co-participation, Text Reminders, Instructional Education, Video-Guided Physical Rehabilitation, and Exercise

    Testing an activity smartwatch program with reminders and rehab videos for dementia

    📍 NYU Langone Health · New York, NY · Get directions →

    This is a multi-methods two-arm, crossover, analyst-blinded randomized controlled trial with embedded qualitative interviews, enrolling 50 dyads (older adult-care partner). Participants will receive the ACTIVE intervention, which includes a Fitbit smartwatch, motivational text messages to engage in walking exercise, instructional educational videos, and virtual physical therapy sessions.

    ✓ Study care freeAges 18+Learn more →
  • Lupus (SLE)

    Dapagliflozin in Active Lupus Nephritis

    Testing dapagliflozin for lupus-related kidney inflammation (kidney disease)

    📍 Massachusetts General Hospital · Boston, MA · +1 more US site · Get directions →

    Lupus nephritis is a chronic and life-threatening autoimmune cause of kidney disease that predominately impacts young people and can lead to kidney failure. Sodium-glucose co-transporter-2 inhibitors, including dapagliflozin, are known to improve outcomes for people with other causes of chronic kidney disease.

    ✓ Study care freePhase 4Ages 18–70Learn more →
  • Dementia / Alzheimer's

    Cognitive and Vascular Functioning Following TBI

    Studying how past brain injury relates to thinking problems and blood vessel changes in people with

    📍 Walter Reed National Military Medical Center · Bethesda, MD · Get directions →

    This observational study will examine the association of chronic traumatic cerebrovascular injury and cardiovascular risk factors with TBI-related cognitive impairment and vascular dementia. Cerebrovascular, inflammatory, and neurodegenerative blood biomarkers as well as clinical and neuroimaging data

    ✓ Study care freeAges 18–74Learn more →
  • Dementia / Alzheimer'sParkinson's disease

    Impact of a Biophoton Therapy on Patients With Brain Disorders

    Testing a light-based therapy for people with dementia or Parkinson’s

    📍 Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001 · Butler, PA · Get directions →

    Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or Parkinson's disease. The current study is to confirm the previous clinical observation by conducting as a randomized, triple-blinded, placebo-controlled prospective intervention clinical research.

    ✓ Study care freeAges 18+Learn more →
  • Dementia / Alzheimer's

    Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

    Testing whether probiotics change lipid levels in people with ALS frontotemporal dementia

    📍 Stan Cassidy Centre for Rehabilitation · Fredericton, New Brunswick · Get directions →

    The aim of this study is to assess the impact of a probiotic formulation on participants with ALS-FTDSD. It is hypothesized that participants given the probiotics will have different lipid profiles compared to participants receiving the placebo at different time points.

    ✓ Study care freeAges 18+Learn more →
  • Dementia / Alzheimer's

    A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)

    Testing a gene therapy in people with a genetic form of frontotemporal dementia

    📍 The Ohio State University (OSU) Wexner Medical Center · Columbus, OH · +2 more US sites · Get directions →

    The goal of this clinical study is to learn about an investigational gene therapy product called AVB-101, which is designed to treat a disease called Frontotemporal Dementia with Progranulin Mutations (FTD-GRN). FTD-GRN is an early-onset form of dementia, a progressive brain disorder that affects behavior, language and movement.

    ✓ Study care freePhase 1Ages 30–75Learn more →
  • Lupus (SLE)

    A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

    Testing enpatoran over 24 weeks for skin lupus symptoms, with or without whole-body disease

    📍 Inland Rheumatology Clinical Trials, Inc. · Upland, CA · +7 more US sites · Get directions →

    The purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous manifestations of lupus erythematosus with or without systemic disease. Study details include: Study Duration: Up to 35 weeks.

    ✓ Study care freePhase 3Ages 18–75Learn more →
  • Showing the first 60 of 550. Add filters or a location to narrow down.